XClose

UCL Cancer Institute

Home
Menu

Welcome to the UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are considering postgraduate study with us, applications to our flagship MSc Cancer programme have now closed for September 2016 entry. 2017 applications will be opening soon. 

News


Pontecorvo Prize awarded to Dr Nicholas McGranahan

This year’s Cancer Research UK Pontecorvo prize for Best PhD Thesis has been awarded to Dr Nicholas McGranahan, who is currently a postdoc with Professor Charles Swanton (UCL Cancer Institute and the Francis Crick Institute). ​This prestigious prize is awarded to Cancer Research UK-funded students who have produced outstanding PhD theses and made the greatest contribution to scientific knowledge in their field.

Published: Jul 27, 2016 12:24:06 PM

New team to develop radiotherapies that target cancer more effectively

Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust. Today, UCL and UCLH welcome Professor Ricky Sharma, a world-leading oncologist from Oxford University specialising in radiotherapy and cancer biology, to lead the new clinical research programme alongside a team of top physicists.

Published: Jul 4, 2016 2:37:19 PM

Improvements in epigenomic sequencing technologies could enhance cancer diagnostics

An international research collaboration led by UCL scientists has developed ways to improve the quality and accuracy of information harvested from epigenome sequencing datasets in two new research papers published jointly in Nature Biotechnology and Nature Communications today. According to the studies, epigenome sequencing technologies can allow for more comprehensive analysis of cancers - a key component in the development of targeted approaches to combat cancer.

Published: Jun 27, 2016 5:09:23 PM

Launch of new clinical research facilities to advance cancer diagnostics and therapies at UCL/UCLH

The final stages of an £8.9 million award to advance cancer medical research facilities at UCL/UCLH, were celebrated last night with a launch event marking the implementation of new cancer genomics and imaging technologies that will support two world-class cancer research programmes. The event, hosted at the UCL Cancer Institute, featured keynote speeches from Dr Jim Smith, MRC Deputy Chief Executive and Chief of Strategy and Professors Mark Emberton, Tim Meyer and Tariq Enver, who will be leading the research projects at UCLH and UCL.

Published: Jun 16, 2016 3:16:06 PM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute is uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.

Events

How will Society Survive to the 22nd Century?

Join some of UCL’s leading researchers for this free event in which they will turn their attention to society's future survival. Thursday 15th September, starting at 6.00pm

Starts: Sep 15, 2016 6:00:00 PM

Support our work

The progress we make in understanding and developing treatments for cancer is made possible by the generous support of individuals, companies and charitable trusts and foundations. Our donors support us every step of the way in the ongoing fight against cancer. 

Find out more about how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.

Donate

Taking action for equality

Athena Swan silver logo

Connect with us

TwitterYoutubeMail